Coromandel International Q3 FY26: Profit down 38% QoQ

Key numbers that moved in the Dec 2025 quarter

Coromandel International Ltd (NSE: COROMANDEL) reported a weaker sequential set of consolidated operating numbers for the quarter ended December 2025. Revenue for the Dec 2025 quarter stood at ₹8,862 crore, down from ₹9,770 crore in the September 2025 quarter. The sequential decline in revenue was reported as 9.29%. Profitability metrics also softened, with EBITDA at ₹882.83 crore versus ₹1,263 crore in the previous quarter. That change was reported as a 30.1% decline.

Net profit for the Dec 2025 quarter came in at ₹488.47 crore, compared with ₹793.44 crore in the September 2025 quarter. The quarter-on-quarter decline in net profit was reported as 38.44%. The Dec 2025 net profit figure was also presented as the “Net Profit - Last Quarter,” last updated on May 06, 2026. These sequential numbers are closely tracked because they show how quickly margins can move in input-led agri businesses.

Dec 2025 vs Sep 2025: a snapshot table

Stock price context from February 2026

A price snapshot in the data shows COROMANDEL at ₹2,256.70 as on 11-Feb-2026 09:59:16 IST. The stock was down ₹12.00, or 0.53%, at that time. This does not directly correspond to the Dec 2025 quarter update date, but it provides a reference point for where the stock traded during FY26. Short-term price moves often reflect a mix of earnings expectations, sector sentiment, and broader market risk appetite.

FY25 results announcement: income and PAT growth

Separately, Coromandel announced financial results for the quarter and year ended 31 March 2025 (dated April 30, 2025). For Q4, total income was reported at ₹5,113 crore versus ₹4,027 crore in Q4 of the previous year, a growth of 27%. PAT for Q4 was ₹389 crore versus ₹209 crore, a growth of 86%. For the year ended 31 March 2025, total income was ₹24,428 crore versus ₹22,308 crore in the previous year, a growth of 10%.

The same FY25 release also shared consolidated figures. Consolidated total income for Q4 was ₹5,114 crore versus ₹3,996 crore in the year-ago quarter. Consolidated PAT for the quarter was ₹578 crore versus ₹164 crore. Consolidated total income for FY24-25 was ₹24,444 crore versus ₹22,290 crore, while consolidated PAT for the year was ₹2,055 crore versus ₹1,641 crore.

A management-style performance readout: volumes driving income

A separate performance note in the input described consolidated total income of ₹5,114 crore for a quarter and ₹24,444 crore for the full year, compared with ₹3,996 crore for the quarter and ₹22,290 crore for the full year in the corresponding period. It stated that this represented growth of 28% for the quarter and 10% for the full year. The note attributed the increase mainly to volume growth across businesses. It also stated consolidated EBITDA for the quarter was ₹426 crore against ₹273 crore in the prior year, and full-year EBITDA was ₹2,628 crore against ₹2,399 crore.

This same set of inputs also referenced formulation business performance, citing 31% growth for the quarter and 16% growth for the full year on a “rupees crore basis,” along with an increase in CPC revenue share driven by domestic formulation and new molecules. The information provides context on which segments were described as supporting growth in that period. However, the dataset does not provide the exact quarter label for these formulation growth percentages.

FY24 pressure points: monsoon, subsidy rates, and crop protection

For the fiscal year 2024, one report in the input stated Coromandel’s consolidated total revenue fell 25% year-on-year to ₹22,290 crore. The same report said net profit fell 18.48% to ₹1,641 crore. It also broke out quarterly revenue by business line, stating nutrient and allied business revenue was ₹3,358 crore and crop protection business revenue was ₹564 crore.

That FY24 note also carried management commentary from Arun Alagappan, executive vice chairman, describing a challenging business environment. The reasons cited were sub-normal monsoons and lower reservoir levels in key operating markets impacting agri-input consumption. It also mentioned sharp corrections in subsidy rates in the second half of the year and global headwinds in crop protection, which led to margin pressure.

FY24 dividend recommendation mentioned in the dataset

The same FY24 report stated the board recommended a final dividend of ₹6 per share for FY24. Dividend announcements matter for investor positioning because they give a signal of cash generation and board stance on payouts. The input does not provide the record date or payment date details. It also does not specify whether the dividend was later approved, so the data is best treated as a recommendation as stated.

FY23-24 annual performance: revenue, profit and margin data

Another FY23-24 dataset in the input stated revenue from operations for the year was ₹22,029 crore, versus ₹29,610 crore last year. It stated profit before interest, depreciation, and taxation stood at ₹2,680 crore compared with ₹3,093 crore in the previous year, a decline of 13% year-on-year. Net profit for the year was ₹1,719 crore, a decrease of 16% from ₹2,035 crore.

The same note said EBITDA margin improved by 104 basis points to 10.90% and PAT margin improved by 93 basis points to 7.80% in FY 2023-24. It also included a small conversion note “(equivalent to ₹0.75 crore)” for the year ended March 31, 2024, without specifying the original base amount in the provided text.

Reported quarter volatility in FY24: Q4 and June quarter references

The input also contains multiple quarter-level references from FY24 that highlight volatility. One headline snippet stated consolidated net profit declined 37.05% to ₹310.97 crore in the quarter ended June 2024. Another report said Coromandel’s consolidated net profit declined 33% to ₹163.91 crore for the quarter ended March (Q4 FY24) and total income fell to ₹1,640.64 crore from ₹2,012.93 crore a year earlier.

A Reuters snippet in the dataset said Coromandel reported a 15% fall in quarterly profit, with consolidated net profit after tax at ₹246 crore compared with ₹290 crore a year earlier, while revenue from operations rose nearly 30% to ₹5,476 crore. It added that a 32% increase in total expenses outpaced revenue growth. These figures are presented as reported in the input and are not reconciled with other quarter figures in the dataset.

Market impact and why the Dec 2025 trend matters

The Dec 2025 quarter’s sequential declines in revenue, EBITDA, and net profit indicate a sharper fall in profitability than in topline, based on the reported percentages. A 9.29% revenue decline alongside a 30.1% EBITDA decline implies margins compressed quarter-on-quarter in that period. The 38.44% net profit drop from ₹793.44 crore to ₹488.47 crore reinforces that the earnings swing was material.

For investors, the broader dataset shows that Coromandel’s results have varied significantly across periods, with FY24 described as pressured by monsoon and subsidy-related factors, while FY24-25 included reported income growth and higher consolidated PAT in the shared figures. For customers and channel partners, such swings can influence product pricing, working capital decisions, and inventory planning, although the input provides no direct operational guidance for Dec 2025.

Conclusion

Coromandel International’s reported Dec 2025 quarter numbers show a clear sequential slowdown, with revenue down to ₹8,862 crore, EBITDA down to ₹882.83 crore, and net profit down to ₹488.47 crore versus the September 2025 quarter. At the same time, the dataset includes FY25 income growth figures and FY24 commentary pointing to weather and subsidy-rate pressures. Investors tracking the stock will likely compare the Dec 2025 margin movement against the earlier periods where volumes and segment mix were cited as supportive. The next set of official quarterly disclosures and any updated management commentary will be key to understanding whether the Dec 2025 profitability dip was temporary or part of a longer pattern.